
| Code | Description | Priority |
|---|---|---|
| 98002 | Interferon alfa 5 use as antiviral for hepatitis C treatment | Sol. ES981003 (3/5/1998) |
| 98003 | Peptide inhibitors of TGF beta 1 | Sol. ES9802465 (24/11/1998) |
| 01008 | Use of Cardiotrophine (CT-1) for the treatment of human liver diseases | Sol. ES200102120 (21/9/2001) |
| 02007 | Peptides Inhibitors of TGF-beta 1 (II) | Sol. ES200302020 (22/8/2003) |
| 03001 | New method for thrombosis risk evaluation by measuring e PCR auto-antibody in plasma | Sol. ES200400269 (06/02/2004) |
| 03004 | Hybrid virus (Adenovirus-alfa/ Semliki Forest) to administer and express therapeutics genes in tumour cells | Sol. ES200401219 (20/05/2004) |
| 04005 | Use of anfirreguline as acute liver protectant agent | Sol. ES200401776 (20/07/2004) |
| 04011 | Oxidised Apo A1 as early markers of Hepatocellular carcinoma | Sol. ES200402989 (16/12/2004) |
| 04007 | New soluble ePCR protein as trombotic marker and potential therapeutic agent | Sol. ES 200500623 (17/03/2005) |
| 04016 | 5'-metiltioadenosina (MTA) in the prevention and treatment of autoimmune diseases | PCT/ES 2005/000139 (17/03/2005) |
| 04012 | Use of C-aminoterminal fragment of cardiotrofina-1 as marker of cardiac insufficiency | PCT/ES 2005/000227 (28/04/2005) |
| 05008 | Use of cardiotrofina-1 (CT-1) and alfa interferon (IFNa) for combined treatment in viral diseases | Sol. ES200501468 (16/06/2005) |
| 05012 | Fibrosis markers in urine | Sol. ES200501611 (01/07/2005) |
| 04018 | Use of EDA as immune-modulator agent | Sol. ES200501412 (13/06/2005) |
| 05013 | A selection of hepatocellular carcinoma markers | Sol. ES200502369 (29/09/2005) |
| 05009 | Immune-stimulatory combination for hepatitis C prevention | Sol. ES200502446 (07/10/2005) Sol. ES200601563 (09/06/2006) |
| 05030 | Use of peptides inhibitor of TGF-beta1 as a immune response modulator | PCT/ES 2005/002446 (24/10/2005) |
| 05019 | New recombinant adenovirus with conditionated replication | Sol. ES200503047 (12/12/2005) |
| 05025 | Use of inhibitory peptides of TGFb for the treatment of bond metastasis | Sol ES20060223923/08/2006 |